201 related articles for article (PubMed ID: 22901569)
1. Cyclosporine A for refractory interstitial cystitis/bladder pain syndrome: experience of 3 tertiary centers.
Forrest JB; Payne CK; Erickson DR
J Urol; 2012 Oct; 188(4):1186-91. PubMed ID: 22901569
[TBL] [Abstract][Full Text] [Related]
2. Efficacy, Side Effects, and Monitoring of Oral Cyclosporine in Interstitial Cystitis-Bladder Pain Syndrome.
Crescenze IM; Tucky B; Li J; Moore C; Shoskes DA
Urology; 2017 Sep; 107():49-54. PubMed ID: 28528859
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: a randomized comparative study.
Sairanen J; Tammela TL; Leppilahti M; Multanen M; Paananen I; Lehtoranta K; Ruutu M
J Urol; 2005 Dec; 174(6):2235-8. PubMed ID: 16280777
[TBL] [Abstract][Full Text] [Related]
4. Fulguration for Hunner ulcers: long-term clinical outcomes.
Hillelsohn JH; Rais-Bahrami S; Friedlander JI; Okhunov Z; Kashan M; Rosen L; Moldwin RM
J Urol; 2012 Dec; 188(6):2238-41. PubMed ID: 23083651
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporine in severe interstitial cystitis.
Forsell T; Ruutu M; Isoniemi H; Ahonen J; Alfthan O
J Urol; 1996 May; 155(5):1591-3. PubMed ID: 8627830
[TBL] [Abstract][Full Text] [Related]
6. Evidence for Early Cyclosporine Treatment for Hunner Lesion Interstitial Cystitis.
Vollstedt A; Tennyson L; Turner K; Hasenau D; Saon M; McCartney T; Beck D; Gilleran J; Peters K
Female Pelvic Med Reconstr Surg; 2022 Jan; 28(1):e1-e5. PubMed ID: 34608034
[TBL] [Abstract][Full Text] [Related]
7. Potassium sensitivity test (PST) as a measurement of treatment efficacy of painful bladder syndrome/interstitial cystitis: a prospective study with cyclosporine A and pentosan polysulfate sodium.
Sairanen J; Tammela TL; Leppilahti M; Onali M; Forsell T; Ruutu M
Neurourol Urodyn; 2007; 26(2):267-70. PubMed ID: 17078084
[TBL] [Abstract][Full Text] [Related]
8. Gene expression analysis of urine sediment: evaluation for potential noninvasive markers of interstitial cystitis/bladder pain syndrome.
Blalock EM; Korrect GS; Stromberg AJ; Erickson DR
J Urol; 2012 Feb; 187(2):725-32. PubMed ID: 22177197
[TBL] [Abstract][Full Text] [Related]
9. Hunner Lesion Phenotype in Interstitial Cystitis/Bladder Pain Syndrome: A Systematic Review and Meta-Analysis.
Lai HH; Pickersgill NA; Vetter JM
J Urol; 2020 Sep; 204(3):518-523. PubMed ID: 32223699
[TBL] [Abstract][Full Text] [Related]
10. Clinical Phenotyping Does Not Differentiate Hunner Lesion Subtype of Interstitial Cystitis/Bladder Pain Syndrome: A Relook at the Role of Cystoscopy.
Doiron RC; Tolls V; Irvine-Bird K; Kelly KL; Nickel JC
J Urol; 2016 Oct; 196(4):1136-40. PubMed ID: 27117441
[TBL] [Abstract][Full Text] [Related]
11. Investigation of a Ca2+ channel α2δ ligand for the treatment of interstitial cystitis: results of a randomized, double-blind, placebo controlled phase II trial.
Nickel JC; Crossland A; Davis E; Haab F; Mills IW; Rovner E; Scholfield D; Crook T
J Urol; 2012 Sep; 188(3):817-23. PubMed ID: 22818144
[TBL] [Abstract][Full Text] [Related]
12. Long-term results of reconstructive surgery in patients with bladder pain syndrome/interstitial cystitis: subtyping is imperative.
Rössberger J; Fall M; Jonsson O; Peeker R
Urology; 2007 Oct; 70(4):638-42. PubMed ID: 17991529
[TBL] [Abstract][Full Text] [Related]
13. Clinical phenotyping of women with interstitial cystitis/painful bladder syndrome: a key to classification and potentially improved management.
Nickel JC; Shoskes D; Irvine-Bird K
J Urol; 2009 Jul; 182(1):155-60. PubMed ID: 19447429
[TBL] [Abstract][Full Text] [Related]
14. Are mast cells still good biomarkers for bladder pain syndrome/interstitial cystitis?
Gamper M; Regauer S; Welter J; Eberhard J; Viereck V
J Urol; 2015 Jun; 193(6):1994-2000. PubMed ID: 25596361
[TBL] [Abstract][Full Text] [Related]
15. Persistent therapeutic effect of repeated injections of onabotulinum toxin a in refractory bladder pain syndrome/interstitial cystitis.
Pinto R; Lopes T; Silva J; Silva C; Dinis P; Cruz F
J Urol; 2013 Feb; 189(2):548-53. PubMed ID: 23253961
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of prostaglandin E2 and E-series prostaglandin receptor in patients with interstitial cystitis.
Wada N; Ameda K; Furuno T; Okada H; Date I; Kakizaki H
J Urol; 2015 Jun; 193(6):1987-93. PubMed ID: 25595860
[TBL] [Abstract][Full Text] [Related]
17. Did patients with interstitial cystitis who failed to respond to initial treatment with bacillus Calmette-Guerin or placebo in a randomized clinical trial benefit from a second course of open label bacillus Calmette-Guerin?
Propert KJ; Mayer R; Nickel JC; Payne CK; Peters KM; Teal V; Burks D; Kusek JW; Nyberg LM; Foster HE;
J Urol; 2007 Sep; 178(3 Pt 1):886-90. PubMed ID: 17631335
[TBL] [Abstract][Full Text] [Related]
18. Sites of pain from interstitial cystitis/painful bladder syndrome.
Warren JW; Langenberg P; Greenberg P; Diggs C; Jacobs S; Wesselmann U
J Urol; 2008 Oct; 180(4):1373-7. PubMed ID: 18707715
[TBL] [Abstract][Full Text] [Related]
19. Preliminary results of suburothelial injection of botulinum a toxin in the treatment of chronic interstitial cystitis.
Kuo HC
Urol Int; 2005; 75(2):170-4. PubMed ID: 16123573
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide as a marker for evaluation of treatment effect of cyclosporine A in patients with bladder pain syndrome/interstitial cystitis type 3C.
Ehrén I; Hallén Grufman K; Vrba M; Sundelin R; Lafolie P
Scand J Urol; 2013 Dec; 47(6):503-8. PubMed ID: 23600529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
